Prognostic value of insulin-like growth factor II mRNA binding protein 3 in patients treated with radical prostatectomy Academic Article uri icon

Overview

MeSH Major

  • Adenocarcinoma
  • Prostatectomy
  • Prostatic Neoplasms
  • RNA-Binding Proteins

abstract

  • IMP3 expression is abnormal in approximately one-fifth of prostate cancers. Although IMP3 is differentially expressed in patients with features of biologically aggressive prostate cancer, it does not have an independent prognostic value in patients treated with RP.

publication date

  • July 2012

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1111/j.1464-410X.2011.10703.x

PubMed ID

  • 22077633

Additional Document Info

start page

  • 63

end page

  • 8

volume

  • 110

number

  • 1